@article{1cfaac828dfc49fd8c7805457be7fb0d,
title = "Chicken Soup in the Time of COVID",
keywords = "COVID-19, chicken soup, clinical trials",
author = "Rennard, {Stephen I.} and Kalil, {Andre C.} and Richard Casaburi",
note = "Funding Information: FINANCIAL/NONFINANCIAL DISCLOSURE: The authors have reported to CHEST the following: S. R. was an employee of AstraZeneca 2015 to 2019 and has consulted with GlaxoSmithKline and BerGenBio, none of which is related to the present work. R. C. is a consultant or is a member of advisory boards for GlaxoSmithKline, AstraZeneca, Regeneron and Genentech and is a member of the speakers{\textquoteright} bureau for GlaxoSmithKline; his institution has received research support funds from Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Regeneron and Genentech. None of these relate to the present work. None declared (A. K.).",
year = "2020",
month = sep,
doi = "10.1016/j.chest.2020.04.044",
language = "English (US)",
volume = "158",
pages = "864--865",
journal = "Diseases of the chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "3",
}